Mutations associated with genotypic resistance to antiretroviral therapy in treatment naı̈ve HIV-1 infected patients in Greece
✍ Scribed by E. Magiorkinis; D. Paraskevis; G. Magiorkinis; S. Chryssou; M. Chini; M. Lazanas; V. Paparizos; G. Saroglou; A. Antoniadou; E. Giamarellou; A. Karafoulidou; A. Hatzakis
- Book ID
- 117365885
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 145 KB
- Volume
- 85
- Category
- Article
- ISSN
- 0168-1702
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract This was an exploratory study to investigate lamivudine‐resistant hepatitis B virus (HBV) strains in selected lamivudine‐naïve HBV carriers with and without human immunodeficiency virus (HIV) co‐infection in South African patients. Thirty‐five lamivudine‐naïve HBV infected patients with
## Abstract To analyze the clinical relevance of AZT resistance mutations in AZT‐naive patients, 56 HIV‐1 seropositive patients treated for 18 months with stavudine/lamivudine (27 patients) or AZT/lamivudine (29 patients) were studied. AZT‐like resistance mutations were found in 13 out of 29 (44%)